Stock Research for DCTH

DCTH
Current Price

$0.0189


Latest Update: 2018-02-16 16:00:00

High
$ 0.0189
Low
$ 0.0186
Close
$ 0.0186
Volume
394120
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

DCTH Stock Chart & Research Data

The DCTH chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DCTH chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


DCTH Due diligence Resources & Stock Charts

The DCTH stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DCTH Detailed Price Forecast - CNN Money CNN View DCTH Detailed Summary - Google Finance
Yahoo View DCTH Detailed Summary - Yahoo! Finance Zacks View DCTH Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View DCTH Trends & Analysis - Trade-Ideas Barrons View DCTH Major Holders - Barrons
NASDAQ View DCTH Call Transcripts - NASDAQ Seeking View DCTH Breaking News & Analysis - Seeking Alpha
Spotlight View DCTH Annual Report - CompanySpotlight.com OTC Report View DCTH OTC Short Report - OTCShortReport.com
TradeKing View DCTH Fundamentals - TradeKing Charts View DCTH SEC Filings - Bar Chart
WSJ View Historical Prices for DCTH - The WSJ Morningstar View Performance/Total Return for DCTH - Morningstar
MarketWatch View the Analyst Estimates for DCTH - MarketWatch CNBC View the Earnings History for DCTH - CNBC
StockMarketWatch View the DCTH Earnings - StockMarketWatch MacroAxis View DCTH Buy or Sell Recommendations - MacroAxis
Bullish View the DCTH Bullish Patterns - American Bulls Short Pains View DCTH Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View DCTH Stock Mentions - StockTwits PennyStocks View DCTH Stock Mentions - PennyStockTweets
Twitter View DCTH Stock Mentions - Twitter Invest Hub View DCTH Investment Forum News - Investor Hub
Yahoo View DCTH Stock Mentions - Yahoo! Message Board Seeking Alpha View DCTH Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for DCTH - SECform4.com Insider Cow View Insider Transactions for DCTH - Insider Cow
CNBC View DCTH Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DCTH - OTC Markets
Yahoo View Insider Transactions for DCTH - Yahoo! Finance NASDAQ View Institutional Holdings for DCTH - NASDAQ


Stock Charts

FinViz View DCTH Stock Insight & Charts - FinViz.com StockCharts View DCTH Investment Charts - StockCharts.com
BarChart View DCTH Stock Overview & Charts - BarChart Trading View View DCTH User Generated Charts - Trading View


Latest Financial News for DCTH

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
Posted on Friday February 02, 2018

NEW YORK, Feb. 02, 2018-- Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe have performed ...


Delcath Announces Satisfaction of 2016 Convertible Note
Posted on Thursday February 01, 2018

NEW YORK, Feb. 01, 2018-- Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has satisfied all of its obligations ...


Delcath Announces Special Protocol Agreement Modification With FDA
Posted on Wednesday January 10, 2018

NEW YORK, Jan. 10, 2018-- Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has concluded a modification agreement ...


Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology
Posted on Tuesday January 09, 2018

NEW YORK, Jan. 09, 2018-- Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that results of a multi-center retrospective ...


Delcath Systems May Take Off In The Near Future
Seeking Alpha - Jul 11, 2017
While a reverse-split is not entirely off the table, it is unlikely even in light of a recent Series B share offering. Even if a reverse split occurs, the company has many near-term catalysts, including two Phase 3 trials and sufficient financing for ...
Delcath Systems, Inc. (NASDAQ:DCTH): Here's Our Take - Insider Financial

Delcath Systems, Inc. (OTCMKTS:DCTH) Remains A Mystery For Investors
Insider Financial - Feb 14, 2018
The firm is a pharmaceutical and medical device company which focuses on oncology and liver cancer therapy. It develops and commercializes Melphalan Hydrochloride for Injection which is a proprietary product for use with the Delcath Hepatic Delivery ...

Delcath: Massive Dilution Ahead
Seeking Alpha - Jul 28, 2017
Delcath Systems' CEO sent a letter to shareholders through SEC filings, asking them to support a reverse split 1-for-20 to 1-for-500.
Delcath Systems (DCTH) Stock: The Good, The Bad, The Ugly, The Opportunity! - CNA Finance (press release)

Delcath: It Is All About Survival
Seeking Alpha - Sep 6, 2017
Delcath CEO Dr. Jennifer Simpson has once again written a letter to shareholders asking for a vote in favor of a reverse split.
Delcath Systems (DCTH) Stock: I Heard The Call… It's A Shame! - CNA Finance (press release)
Lookout for Price Target? Delcath Systems, Inc. (DCTH), Bank of America ... - StockNewsJournal

Enter a stock symbol to view the stock details.